Characterization of BshA, bacillithiol glycosyltransferase from Staphylococcus aureus and Bacillus subtilis  by Upton, Heather et al.
FEBS Letters 586 (2012) 1004–1008journal homepage: www.FEBSLetters .orgCharacterization of BshA, bacillithiol glycosyltransferase from Staphylococcus
aureus and Bacillus subtilis
Heather Upton a, Gerald L. Newton b, Melissa Gushiken a, Kelly Lo b, Dhiraj Holden a, Robert C. Fahey b,
Mamta Rawat a,⇑
aDepartment of Biology, California State University-Fresno, Fresno, CA 93740, USA
bDepartment of Chemistry and Biochemistry, The University of California at San Diego, La Jolla, CA 92093-0314, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 22 December 2011
Revised 14 February 2012
Accepted 17 February 2012
Available online 6 March 2012
Edited by Stuart Ferguson
Keywords:
Mycothiol
Bacillithiol
Glycosyltransferase
Mycobacteria
Thiol
Staphylococcus aureus0014-5793/$36.00  2012 Federation of European Bio
doi:10.1016/j.febslet.2012.02.028
Abbreviations: BSH, bacillithiol; MSH, mycothiol
glucosamine; GlcNAc-Mal, N-acetylglucosaminylmala
5,50-dithiobis(2-nitrobenzoic acid); TCEP, Tris(2-carbo
⇑ Corresponding author. Fax: +1 559 278 3963.
E-mail address: mrawat@csufresno.edu (M. RawatThe ﬁrst step during bacillithiol (BSH) biosynthesis involves the formation of N-acetylglucosami-
nylmalate from UDP-N-acetylglucosamine and L-malate and is catalyzed by a GT4 class glycosyl-
transferase enzyme (BshA). Recombinant Staphylococcus aureus and Bacillus subtilis BshA were
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In nearly all eukaryotes, glutathione is the major low-molecular
weight thiol that serves as a cofactor for a wide range of enzymes
involved in protecting against reactive oxygen species, reactive
nitrogen species, and many other toxins. GSH is found in most
Gram-negative bacteria, including cyanobacteria, but only rarely
in Gram-positive bacteria, which include a wide range of human
pathogens. In the high GC actinobacteria, a low-molecular-weight
cysteine derivative called mycothiol (MSH) is the major thiol [1]
while in the low GC Gram-positive bacteria, a similar thiol, bacil-
lithiol (BSH), is present [2]. Both MSH and BSH contain the cystei-
nylglucosamine core moiety but in BSH L-malic acid is substituted
for myo-inositol and the cysteine amino group is not acylated
(Fig. 1a and b).
The ﬁrst step in MSH biosynthesis involves the formation of
N-acetylglucosaminylinositol-3-phosphate from UDP-N-acetyl glu-
cosamine (UDP-GlcNAc) and 1-L-inositol-1-phosphate, a processchemical Societies. Published by E
; UDP-GlcNAc, UDP-N-acetyl
te; DTT, dithiothreitol; DTNB,
xyethyl) phosphine
).catalyzed by a GT4 class glycosyltransferase (MshA) [3]. A similar
ﬁrst step occurs during BSH biosynthesis where a Bacillus subtilis
GT4 class glycosyltransferase enzyme (BshA) catalyzes the formation
of N-acetylglucosaminylmalate (GlcNAc-Mal) from UDP-GlcNAc and
L-malate (Fig. 1d) [4]. In 2008, Ruane et al. reported the crystal struc-
ture of a putative glycosyltransferase, ORF BA1558, which is the
Bacillus anthracis homolog of BshA [5]. Parsonage et al. reported
the structure of this B. anthracis BshA with UDP-malate ternary
complex and described the phenotype of the mutant disrupted in
this gene [6]. Herein, we report on the characterization of B. subtilis
BshA and Staphylococcus aureus BshA and show that BSH is able to
inhibit BshA. As a dominant thiol in signiﬁcant pathogens, BSH
biochemistry, in particular enzymes like BshA that are involved
in the biosynthesis of BSH, may prove to be good targets for anti-
biotics directed against these pathogens.2. Materials and methods
2.1. Cloning and expression of B. subtilis and S. aureus BshA
BshA was PCR ampliﬁed from B. subtilis JH642 using primers
BshAN5 (50-CACCATGAGAAAACTAAA AATAGGA) and BshAN3
(50-TCACTCCGGTTCTGCTAAATCGGC) and proofreading Pfu DNAlsevier B.V. All rights reserved.
Fig. 1. Structure of (a) mycothiol, (b) bacillithiol, (c) O-UDP-N-acetylglucosamine (oxidized UDP-N-acetylglucosamine); note that the ribose moiety in UDP-N-
acetylglucosamine has been oxidized to a dialdehydo-moiety, and (d) BshA glycosyl transferase reaction.
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TOPO vector (Invitrogen) and expressed in BL-21 Star (DE3) pLysS
Escherichia coli strain as the N-terminal His-6 tagged protein. The
protein was puriﬁed to homogeneity on a chelate chromatography
nickel column (Clontech). The eluted proteins were dialyzed
against the BshA assay buffer, 100 mM NaCl, 10 mM MgCl2, and
25 mM HEPES pH 7.5, to which 1 mM b-mercaptoethanol was
added and concentrated with Centricon 30 ultraﬁlter (Amicon)
and snap frozen in 10% glycerol. Similarly, the S. aureus BshA was
PCR ampliﬁed using SBshAN5 (50-CACCATGAAGATAGGTATAAC)
and SBshAN3 (50-TTACTCGCCTTTACTTTTGTT), expressed and puri-
ﬁed using PrepEase His tag protein puriﬁcation Prep (USB Corpora-
tion). The BshA protein fraction was loaded onto a Sephadex G25
column to remove the imidazole and eluted with BshA assay buffer
to which 2 mM dithiothreitol (DTT) was added. S. aureus BshA was
snap frozen in individual aliquots in glycerol as it eluted off the
column.
2.2. Assay for glycosyltransferase activity
S. aureus and B. subtilis BshA were assayed in 100 mM NaCl,
10 mM MgCl2, and 25 mM HEPES pH 7.5 at 37 C with 2 mM DTT
and 1 mM b-mercaptoethanol added to the buffer, respectively.
The consumption of UDP-GlcNAc and release of UDP were analyzed
by HPLC with detection of peaks spectrophotometrically at 260 nmas previously described for MshA with minor modiﬁcations [3]. The
following HPLC conditions were used: Buffer A: 2 mM tetrabutyl-
ammonium phosphate, pH 5.4; Buffer B: 20 mM KH2PO4, 50%
methanol, 10 mM tetrabutylammonium phosphate, pH 5.4; elution
program: 0–1 min, 15% B; 1–31 min, linear 15–100% Buffer B;
31–32 min, linear 100–15% Buffer B; 45 min reinjection. The reten-
tion times for the standards, uridine, UMP, UDP-GlcNAc, UDP, and
UTP were 4.9, 14.2, 20.5, 21.9, and 25.6 min, respectively. S. aureus
BshA substrate speciﬁcity and B. subtilis BshA substrate speciﬁcity
was determined.
2.3. Inhibition of BshA and MshA glycosyltransferase with BSH, MSH
and O-UDP-GlcNAc
B. subtilisBshAwas preincubated for 15 min at 37 Cwith various
concentrations of BSH [15], diluted into the BshA reaction mixture,
and glycosyltransferase activity was measured as the release of
UDP as described above. The dose–response curves for BSH were
determined in duplicate and half maximal inhibitory concentration
(IC50) calculated from these curves. Likewise, Mycobacterium
smegmatis cell lysate was preincubatedwith various concentrations
of MSH [16] and diluted into the MshA reaction mixture containing
1 mM 1-L-inositol-1-phosphateand 1 mM UDP-GlcNAc. To deter-
mine if 20,30-dialdehydo-UDP-N-acetylglucosamine (O-UDP-GlcNAc;
Fig. 1c) from oxidation of UDP-GlcNAc inhibits BshA and/or MshA
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with various concentrations of O-UDP-GlcNAc and activity assays
performed.
2.4. Size determination of BshA glycosyl transferase
Gel ﬁltration using Sephacryl 200 was used to determine the
native molecular weight for both S. aureus and B. subtilis BshA.
The following proteins were used to calibrate the column: cyto-
chrome C, ovalbumin, bovine serum albumin, phophorylase B,
aldehyde dehydrogenase, b amylase, and apoferritin.
2.5. Thiol determination
Brieﬂy, 60 lg of puriﬁed protein was treated with 10 mM DTT,
10 mM diamide, or water at room temperature for 15 min. To
denature the protein and stop the reaction, acetonitrile was added
to the reaction followed by centrifugation to collect the pelleted
protein. The pelleted protein was washed, brought up in 100 ll of
6 M guanidine HCl, and incubated at 37 C for 25 min. Protein con-
centration was determined bymeasuring absorbance at 280 nm. To
measure the thiol content, the samples were treated with 0.16 mM
5,50-dithiobis(2-nitrobenzoic acid) (DTNB) for 15 min and the
absorbance at 412 nm was measured.
2.6. Molecular modeling and data analysis
To determine basic kinetic parameters for each substrate, initial
velocity plots at saturating concentrations of one substrate were ﬁt
to the Michaelis–Menten equation. All data were analyzed using
KaleidaGraph (Synergy Software).
Protein threading on B. subtilis and S. aureus BshA was per-
formed using B. anthracis BA1558 X-ray crystal structure (PDB
accession No. 2JJM) with IP, integer programming-based threading
engine of RAPTOR [8] 3D structure modeling tool OWL and dis-
played with MolScript [9].Table 1
Apparent Km and Vmax of Staphylococcus aureus and Bacillus subtilis BshA. For L-malate
concentration dependence, 10 mM UDP-N-acetylglucosamine (UDP-GlcNAc) ﬁxed
and L-malate concentration varied from 0.1 to 3.2 mM; for UDP-GlcNAc concentration
dependence, 3 mM of L-malate ﬁxed and UDP-GlcNAc varied from 1 to 15 mM; and,
0.35 lg BshA added to the reactions.
Substrate Km (lM) Vmax (nmol min1 mg1)
L-malate
S. aureus 710 ± 110 35600 ± 1800
B. subtilis 410 ± 70 11200 ± 100
UDP-GlcNAc
S. aureus 250 ± 110 34200 ± 3700
B. subtilis 370 ± 94 8700 ± 1003. Results and discussion
We recently identiﬁed the gene, bshA, responsible for the ﬁrst
step in the biosynthesis of BSH in B. subtilis [4]. This gene codes
for a retaining glycosyltransferase which uses L-malate as the
acceptor substrate and UDP-GlcNAc as the donor substrate. Disrup-
tion of this gene in B. subtilis results in sensitivity to alkylating
agents, fosfomycin and methylglyoxal, indicating involvement of
BSH in detoxiﬁcation of toxins, sensitivity to environmental stres-
ses such as osmotic stress and acid stress, and a decrease in spor-
ulation [4].
In this report, we present a characterization of B. subtilis BshA
and the medically relevant S. aureus BshA. When the two genes
were expressed in E. coli, the resulting recombinant proteins be-
haved very differently during the puriﬁcation process. B. subtilis
BshA puriﬁcation resulted in a good yield and the protein remained
soluble even after concentration to 7 mg ml1; however, S. aureus
BshA started precipitating as the protein eluted off the Ni+ afﬁnity
column. Thus, we switched to commercially prepared Prep Ease
His Tag Protein Puriﬁcation columns for rapid puriﬁcation of the
protein followed by Sephadex G25 gel ﬁltration column to rid elu-
ent of imidazole. As the fractions were eluted, they were frozen in
10% glycerol to prevent further precipitation.
Both recombinant S. aureus and B. subtilis BshA exhibited
marked activity when assayed by HPLC for UDP production using
UDP-GlcNAc and L-malate as substrates. Both substrates exhibited
Michaelis–Menten kinetics in the initial velocity plots for L-malate
and UDP-GlcNAc, and no curvature was seen in the Lineweaver–Burk linear replots (data not shown). The kinetic parameters for
each substrate were determined after ﬁtting to the Michaelis–
Menten Equation. The apparent Km for UDP-GlcNAc at 3 mM ma-
late is within the signiﬁcant error range (250 ± 110 lM for S. aureus
and 370 ± 94 lM for B. subtilis) (Table 1). The apparent Km for UDP-
GlcNAc reported for B. anthracis BshA is equal to that of B. subtilis at
370 lM determined with the HPLC assay [6] and the apparent Km
for UDP-GlcNAc for Corynebacterium glutamicum MshA is
210 ± 20 lM [10]. In contrast, the apparent Km for L-malate is not
within the signiﬁcant error range between the S. aureus and B. sub-
tilis enzymes (710 ± 110 lM for S. aureus BshA and 410 ± 70 lM for
B. subtilis BshA) and the Vmax for the S. aureus enzyme is also 3 to 4-
fold higher than the B. subtilis enzyme. Substrate speciﬁcity studies
further highlight the differences between the two enzymes with S.
aureus BshA showing measurable speciﬁc activity with not only L-
malate but D-glyceric acid and B. subtilis BshA showing measurable
speciﬁc activity with L-malate and the entantiomer D-malate (Ta-
ble 2). The kcat calculated from the UDP-GlcNAc Vmax is 24–25 s1
and 6.1–7.8 s1 for S. aureus and B. subtilis BshA, respectively. In
comparison, the kcat for B. anthracis BshA [6] and C. glutamicum
MshA [10] are 28 s1and 12.5 s1, respectively.
In 2008, Ruane and colleagues [5] ﬁrst reported the structure of
B. anthracis BshA (BA1558). Parsonage et al. further crystallized
this enzyme in complex with UDP and malate [6]. B. anthracis BshA
has 63.1% sequence identity and 77.6% sequence similarity to B.
subtilis BshA and 53.2% sequence identity and 72.5% sequence sim-
ilarity to S. aureus BshA. We thus modeled the S. aureus and B. sub-
tilis BshA on B. anthracis BshA. Molecular modeling indicated that
all three proteins contain the typical GT-B fold of glycosyltransfer-
ases, which consists of two ‘‘Rossmann-like’’’ beta/alpha/beta do-
mains separated by a deep crevice in the inter-domain region
and a kinked C-terminal a-helix that crosses over from the C-ter-
minal domain to contact the N-terminal domain [5]. However
there are some differences, most notably in the position of active
site residues among the three proteins (Fig. 2). The active site
Lys211 (Lys212 in B. subtilis BshA, Lys209 in S. aureus BshA), which
binds to one of the phosphate oxygens of UDP, is present in an a-
helix in approximately the same position in all three structures. On
the other hand, the B. anthracis BshA His120 and B. subtilis BshA
His121, which binds to malate, is present at the end of the b-sheet
while S. aureus BshA His118 is in the middle of a b sheet. Also, the
positions of the B. anthracis BshA Glu282 and Glu290 binding sites
and the relevant amino acids in B. subtilis BshA (Glu283, Glu291)
and S. aureus BshA (Glu280, Glu288) are very different among
the three protein structures. Both residues are involved in sub-
strate recognition of UDP, Glu282 binding to one of the phosphate
oxygens of UDP and Glu290 binding to the ribose-20-OH and ri-
bose-30-OH. These variations in the structure of the proteins may
account for the difference in the behavior of the enzymes.
Ruane et al. [5] reported that B. anthracis monomers are ar-
ranged into a tetramer and Parsonage et al. [6] conﬁrmed that B.
anthracis BshA consists of eight monomers arranged as a dimer
Table 2
Substrate speciﬁcity of S. aureus and B. subtilis BshA. For B. subtilis BshA, reaction conditions consisted of 0.3mM acceptor substrate, 1.0 mM UDP-
GlcNAc and 0.16 lg BshA. For S. aureus BshA, reaction conditions consisted of 0.7 mM acceptor substrate, 3.0 mM UDP-GlcNAc and 0.048 lg BshA.
Substrate S. aureus B. subtilis
Speciﬁc activity (nmol min1 mg1) Relative rate (%) Speciﬁc activity (nmol min1 mg1) Relative rate (%)
L-malic acid 18600 ± 6300 100 6600 ± 150 100
D-malic acid <100 <0.5 230 ± 8 3.4
Inositol-1-L-phosphate <100 <0.5 <100 <0.5
Glycolic acid <100 <0.5 <100 <0.5
L-lactic acid <100 <0.5 <100 <0.5
D, L-isocitric acid <100 <0.5 <100 <0.5
D-glyceric acid 430 ± 180 2.3 <100 <0.5
Citric acid <100 <0.5 <100 <0.5
Fig. 2. 3D structure of B. subtilis and S. aureus BshA, (a) B. anthracis BshA (BA1558), (b) B. subtilis BshA, and (c) S. aureus BshA. Residues identiﬁed in S. aureus and B. subtilis are
equivalent to B. anthracis residue numbers.
Fig. 3. Inhibiton of B. subtilis BshA by BSH. (a) B. subtilis BshA (0.71 lg) preincu-
bated with BSH and assayed for BshA activity with 0.5 mM UDP-GlcNAc and0.5 mM
L-malate.
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are also tetramers, gel ﬁltration chromatography of puriﬁed re-
combinant proteins was conducted. B. subtilis BshA is composed
of 377 amino acid residues with a monomer molecular weight of
42 kDa, respectively. Analysis by gel ﬁltration chromatography
yielded apparent molecular weights of 160,000 kDa, suggesting
that B. subtilis BshA is a tetramer. However, we were unable to
determine the size of S. aureus BshA even after treatment with
reducing agents, DTT and Tris(2-carboxyethyl) phosphine (TCEP)
and alkylating agent, iodoacetamide, which resulted in precipita-
tion of protein during gel ﬁltration chromatography. To examine
the oligomeric state of S. aureus BshA, thiol titration was performed
in guanidine HCl using DTNB. In S. aureus BshA, three out of the
four cysteines were free upon treatment with DTT and pretreat-
ment with diamide, which oxidized the cysteines, did not yield
any free thiols. These results suggest that either one of the cysteine
in the native protein is buried and inaccessible to DTT or is in the
disulﬁde form. S. aureus BshA is thus also likely to form a disulﬁde
linked dimer.
Regulation of BSH synthesis is likely to be multifactorial, includ-
ing transcriptional control and feedback inhibition. GshA, c-gluta-
mate–cysteine ligase, which catalyzes the ﬁrst of two steps in the
pathway for the biosynthesis of glutathione, is feedback-inhibited
by glutathione [11] and CoA inhibits pantethonate kinase, the ﬁrst
enzyme in the CoA biosynthesis pathway [12]. To determine
whether MSH and BSH biosynthesis are regulated by feedback
inhibition, B. subtilis BshA and M. smegmatis cell lysate were prein-
cubated with BSH and MSH, respectively, followed by the enzy-
matic assay. The IC50 for BSH inhibition of BshA is 0.7 mM,
within the biological range for this thiol (Fig. 3), and the IC50 for
MSH inhibition of MshA is 3.6 mM, also within the biological range
for this thiol (Fig. 4a). Thus like glutathione and CoA, the levels ofBSH of MSH are modulated by feedback inhibition of the ﬁrst en-
zyme in the biosynthetic pathway.
BshA and MshA catalyze the ﬁrst committed step in BSH and
MSH biosynthesis, respectively and thus these enzymes are consid-
ered to be potential drug targets. Recently, Frantom et al. reported
that UDP-(5F)-GlcNAc, a sugar nucleotide with an electron with-
drawing substituent, acts as a slow-binding, competitive inhibitor
Fig. 4. (a) M. smegmatis cell free extract (2.7 mg total protein) preincubated with
MSH and assayed for MshA activity with 1 mMUDP-GlcNAc and 1 mM 1-L-inositiol-
1-phosphate. (b) M. smegmatis cell free extract preincubated with O-UDP-GlcNAc
and assayed for MshA activity with 1 mM UDP-GlcNAc and 1 mM 1-L-inositiol-1-
phosphate. Control MshA rates, without inhibitor, were 0.4 nmol min1
mg protein1.
1008 H. Upton et al. / FEBS Letters 586 (2012) 1004–1008of C. glutamicum MshA (Ki 1.6 lM) [13]. O-UDP-GlcNAc (Fig. 1c)
inhibits UDP-N-acetylglucosamine 2-epimerase by binding to the
UDP-GlcNAc binding site irreversibly [14]. As UDP-GlcNAc is a sub-
strate for both BshA and MshA, O-UDP-GlcNAc was assayed for its
ability to inhibit these enzymes. Preincubation of the inhibitor
with the M. smegmatis cell lysate followed by the MshA assayresulted in an IC50 of 0.2 mM for MshA (Fig. 4b). Similar inhibition
studies of BshA with O-UDP-GlcNAc did not show consistent
inhibition. This inhibitor may serve as a basis for the chemical syn-
thesis of further inhibitors for MshA.
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